Kaberi Dasgupta’s studies focus on the remission, prevention, and management of gestational diabetes, type 2 diabetes and related complications. In collaboration with her multidisciplinary team, including patient partners, she develops and tests strategies to enhance self-management support. This includes the creation of VPN, a virtual peer support group for youth with type 1 diabetes, formed after demonstration of high levels of stigma in this population, associated with both elevated A1C and severe hypoglycemia (JMIR, 2018). She has over 130 peer-reviewed publications and holds research grants as principal investigator from the Canadian Institutes of Health Research, the Heart & Stroke Foundation of Canada, and the Lawson Foundation. She is particularly recognized for her trial SMARTER that demonstrated impacts of physician-delivered step count prescriptions on glycemic control in type 2 diabetes (Diabetes, Obesity, and Metabolism, 2017) and a series of epidemiological studies delineating associations of gestational diabetes with type 2 diabetes in mothers and fathers and type 1 diabetes in young offspring (Diabetes Care, 2015; AJE, 2017, CMAJ, 2019).